Literature DB >> 31431730

Preventing the development of hepatitis C in uninfected transplant recipients.

Katrina Ray1.   

Abstract

Entities:  

Year:  2019        PMID： 31431730     DOI： 10.1038/s41575-019-0203-1

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.

Authors:  Emily D Bethea; Kerry Gaj; Jenna L Gustafson; Andrea Axtell; Taylor Lebeis; Mark Schoenike; Karen Turvey; Erin Coglianese; Sunu Thomas; Christopher Newton-Cheh; Nasrien Ibrahim; William Carlson; Jennifer E Ho; Ravi Shah; Matthew Nayor; Thais Gift; Sarah Shao; Amanda Dugal; James Markmann; Nahel Elias; Heidi Yeh; Karin Andersson; Daniel Pratt; Irun Bhan; Kassem Safa; Jay Fishman; Camille Kotton; Paul Myoung; Mauricio A Villavicencio; David D'Alessandro; Raymond T Chung; Gregory D Lewis
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.